Current Pharmaceutical Biotechnology
Title:Preface: Studies on Understanding and Anti-Tumor Agents of Reproductive Cancer Cells
Volume: 18 Issue: 1
Author(s): Cheorl-Ho Kim
Affiliation:
Keywords: Breast cancer, prostate cancer, leiomyoma, gangliosides, steroid receptors, chemoprevention, anti-tumor activity, cell signaling.
Export Options
About this article
Cite this article as:
Kim Cheorl-Ho, Preface: Studies on Understanding and Anti-Tumor Agents of Reproductive Cancer Cells, Current Pharmaceutical Biotechnology 2017; 18 (1) . https://dx.doi.org/10.2174/138920101801170113222330
DOI https://dx.doi.org/10.2174/138920101801170113222330 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advances in Transient Receptor Potential Vanilloid-2 Channel Expression and Function in Tumor Growth and Progression
Current Protein & Peptide Science Subject Index To Volune 2
Current Cancer Therapy Reviews Assembly of Quinoline, Triazole and Oxime Ether in a Single Molecular Entity: A Greener and One-pot Synthesis of Novel Oximes as Potential Cytotoxic Agents
Letters in Drug Design & Discovery Lipid Nanoparticles and their Application in Nanomedicine
Current Pharmaceutical Biotechnology Pharmacological Properties of Thalidomide and its Analogues
Recent Patents on Inflammation & Allergy Drug Discovery Endoradiotherapy with Peptides - Status and Future Development
Current Medicinal Chemistry Anti-diabetic Drug Metformin: Challenges and Perspectives for Cancer Therapy
Current Cancer Drug Targets Aspirin: from a Historical Perspective
Recent Patents on Cardiovascular Drug Discovery Triterpenoids for Cancer Prevention and Treatment: Current Status and Future Prospects
Current Pharmaceutical Biotechnology Use of the Semiconductor Nanotechnologies “Quantum Dots” for in vivo Cancer Imaging
Recent Patents on Anti-Cancer Drug Discovery Prostate Cancer with Variants in CYP17 and UGT2B17 Genes: A Meta-Analysis
Protein & Peptide Letters Phytosynthesized Nanoparticles for Effective Cancer Treatment: A Review
Nanoscience & Nanotechnology-Asia Radioimmunotherapy of Solid Tumors: Searching for the Right Target
Current Drug Delivery Planning of External Beam Radiotherapy for Prostate Cancer Guided by PET/CT
Current Radiopharmaceuticals Nanoparticles for Targeting of Prostate Cancer
Current Pharmaceutical Design Near Infrared Receptor-Targeted Nanoprobes for Early Diagnosis of Cancers
Current Medicinal Chemistry Structure-Activity Relationship Analyses of Glycyrrhetinic Acid Derivatives as Anticancer Agents
Mini-Reviews in Medicinal Chemistry Survivin: Role in Normal Cells and in Pathological Conditions
Current Cancer Drug Targets 68Ga/64Cu PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different Tracers
Current Radiopharmaceuticals Flavonoids Active Against Osteosarcoma: A Review of the Molecular Mechanisms Involved
Current Pharmaceutical Design